Treatment of ricin A-chain-induced hepatotoxicity with liposome- encapsulated N-acetylcysteine

Journal of Drug Targeting

Volumn 19, Issue 9, 2011, Pages 821-829

  Buonocore, Caroline ^a   Alipour, Misagh ^b   Omri, Abdelwahab ^b   Pucaj, Kresimir ^c   Smith, Milton G ^d   Suntres, Zacharias E ^a,b  

^a LAKEHEAD UNIVERSITY   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

^c Nucro Technics   (Canada)

^d Amaox Ltd   (United States)

Author keywords

Antioxidants; Inflammation; Liposomes; Liver; N acetylcysteine; Oxidative stress; Reactive oxygen species

Indexed keywords

3 NITROTYROSINE; ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; LIPOSOME; MYELOPEROXIDASE; RICIN A; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; ENZYME ACTIVITY; INFLAMMATION; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CHEMICAL WARFARE AGENTS; DRUG-INDUCED LIVER INJURY; INFLAMMATION; LIPID PEROXIDATION; LIPOSOMES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RICIN;

EID: 80054692473     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.582645     Document Type: Article

References (70)

1. Alipour M, Omri A, Smith MG, Suntres ZE. (2007). Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J Endotoxin Res, 13, 297-304 (Pubitemid 350056225)
2. Allen TM. (1988). Toxicity of drug carriers to the mononuclear phagocyte system. Adv Drug Deliv Rev, 2, 55-67
3. Baenziger JU, Fiete D. (1979). Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides. J Biol Chem, 254, 9795-9799
4. Baffy G. (2009). Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol, 51, 212-223
5. Balint GA. (2000). Ultrastructural study of liver cell damage induced by ricin. Exp Toxicol Pathol, 52, 413-417
6. Baluna R, Vitetta ES. (1999). An in vivo model to study immunotoxininduced vascular leak in human tissue. J Immunother, 22, 41-47 (Pubitemid 29042289)
7. Battelli MG, Buonamici L, Polito L, Bolognesi A, Stirpe F. (1996). Hepatoxicity of ricin, saporin or a saporin immunotoxin: xanthine oxidase activity in rat liver and blood serum. Virchows Arch, 427, 529-535 (Pubitemid 126828185)
8. Begriche K, Igoudjil A, Pessayre D, Fromenty B. (2006). Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion, 6, 1-28
9. Bingen A, Creppy EE, Gut JP, Dirheimer G, Kirn A. (1987). The Kupffer cell is the first target in ricin-induced hepatitis. J Submicrosc Cytol, 19, 247-256 (Pubitemid 17083818)
10. Blakey DC, Skilleter DN, Price RJ, Thorpe PE. (1988). Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivo. Biochim Biophys Acta, 968, 172-178
11. Bourrie BJ, Casellas P, Blythman HE, Jansen FK. (1986). Study of the plasma clearance of antibody-ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin. Eur J Biochem, 155, 1-10 (Pubitemid 16077752)
12. Cutrn JC, Perrelli MG, Cavalieri B, Peralta C, Rosell Catafau J, Poli G. (2002). Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med, 33, 1200-1208 (Pubitemid 35246588)
13. Doan LG. (2004). Ricin: mechanism of toxicity, clinical manifestations, and vaccine development. A review. J Toxicol Clin Toxicol, 42, 201-208 (Pubitemid 38758534)
14. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. (1998). Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature, 391, 393-397 (Pubitemid 28093514)
15. El-Nikhely N, Helmy M, Saeed HM, Abou Shama LA, Abd El-Rahman Z. (2007). Ricin A Chain from Ricinus sanguineus: DNA sequence, structure and toxicity. Protein J, 26, 481-489 (Pubitemid 47573260)
16. Fiani ML, Blum JS, Stahl PD. (1993). Endosomal proteolysis precedes ricin A-chain toxicity in macrophages. Arch Biochem Biophys, 307, 225-230 (Pubitemid 24001556)
17. Fox ES, Leingang KA. (1998). Inhibition of LPS-mediated activation in rat Kupffer cells by N-acetylcysteine occurs subsequent to NF-kappaB translocation and requires protein synthesis. J Leukoc Biol, 63, 509-514 (Pubitemid 28163192)
18. Glantzounis GK, Yang W, Koti RS, Mikhailidis DP, Seifalian AM, Davidson BR. (2006). The role of thiols in liver ischemia-reperfusion injury. Curr Pharm Des, 12, 2891-2901 (Pubitemid 44184623)
19. Hassoun EA, Wang X. (1999). Time- and concentration-dependent production of superoxide anion, nitric oxide, DNA damage and cellular death by ricin in the J774A.1 macrophage cells. J Biochem Mol Toxicol, 13, 179-185 (Pubitemid 129705390)
20. He Q, Kim J, Sharma RP. (2005). Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. Toxicology, 207, 137-147 (Pubitemid 39601693)
21. Ischiropoulos H. (1998). Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys, 356, 1-11 (Pubitemid 28364347)
22. Ishida T, Harashima H, Kiwada H. (2002). Liposome clearance. Biosci Rep, 22, 197-224 (Pubitemid 35222732)
23. Jaeschke H, Hasegawa T. (2006). Role of neutrophils in acute inflammatory liver injury. Liver Int, 26, 912-919 (Pubitemid 44323408)
24. Johnston DE, Jasuja R. (1994). Purification of cultured primary rat hepatocytes using selection with ricin A subunit. Hepatology, 20, 436-444 (Pubitemid 24233372)
25. Korcheva V, Wong J, Corless C, Iordanov M, Magun B. (2005). Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome. Am J Pathol, 166, 323-339 (Pubitemid 40051684)
26. Korcheva V, Wong J, Lindauer M, Jacoby DB, Iordanov MS, Magun B. (2007). Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages. Mol Immunol, 44, 2761-2771 (Pubitemid 46240306)
27. Kumar O, Lakshmana Rao PV, Pradhan S, Jayaraj R, Bhaskar AS, Nashikkar AB, Vijayaraghavan R. (2007). Dose dependent effect of ricin on DNA damage and antioxidant enzymes in mice. Cell Mol Biol (Noisy-le-grand), 53, 92-102 (Pubitemid 350164310)
28. Kumar O, Sugendran K, Vijayaraghavan R. (2003). Oxidative stress associated hepatic and renal toxicity induced by ricin in mice. Toxicon, 41, 333-338 (Pubitemid 36144172)
29. Licastro F, Morini MC, Bolognesi A, Stirpe F. (1993). Ricin induces the production of tumour necrosis factor-alpha and interleukin-1 beta by human peripheral-blood mononuclear cells. Biochem J, 294 (Pt 2), 517-520 (Pubitemid 23268855)
30. Lord MJ, Jolliffe NA, Marsden CJ, Pateman CS, Smith DC, Spooner RA, Watson PD, Roberts LM. (2003). Ricin. Mechanisms of cytotoxicity. Toxicol Rev, 22, 53-64
31. Magnsson S, Berg T. (1993). Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem J, 291 (Pt 3), 749-755 (Pubitemid 23148448)
32. Magnusson S, Kjeken R, Berg T. (1993). Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells. Exp Cell Res, 205, 118-125 (Pubitemid 23192110)
33. Mandal AK, Das S, Basu MK, Chakrabarti RN, Das N. (2007). Hepatoprotective activity of liposomal flavonoid against arseniteinduced liver fibrosis. J Pharmacol Exp Ther, 320, 994-1001 (Pubitemid 46294072)
34. Mitsopoulos P, Omri A, Alipour M, Vermeulen N, Smith MG, Suntres ZE. (2008). Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. Int J Pharm, 363, 106-111
35. Mitsopoulos P, Suntres ZE. (2010). Cytotoxicity and gene array analysis of alveolar epithelial A549 cells exposed to paraquat. Chem Biol Interact, 188, 427-436
36. Muldoon DF, Hassoun EA, Stohs SJ. (1992). Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice. Toxicon, 30, 977-984
37. Muldoon DF, Stohs SJ. (1994). Modulation of ricin toxicity in mice by biologically active substances. J Appl Toxicol, 14, 81-86 (Pubitemid 24124981)
38. Neuschwander-Tetri BA, Bellezzo JM, Britton RS, Bacon BR, Fox ES. (1996). Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells. Biochem J, 320 (Pt 3), 1005-1010 (Pubitemid 27013820)
39. Oku N, Namba Y. (1994). Long-circulating liposomes. Crit Rev Ther Drug Carrier Syst, 11, 231-270
40. Patsoukis N, Georgiou CD. (2004). Determination of the thiol redox state of organisms: new oxidative stress indicators. Anal Bioanal Chem, 378, 1783-1792 (Pubitemid 40877658)
41. Pattison DI, Davies MJ. (2006). Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr Med Chem, 13, 3271-3290 (Pubitemid 44669775)
42. Rainey GJ, Young JA. (2004). Antitoxins: novel strategies to target agents of bioterrorism. Nat Rev Microbiol, 2, 721-726 (Pubitemid 39200063)
43. Ramsden CS, Drayson MT, Bell EB. (1989). The toxicity, distribution and excretion of ricin holotoxin in rats. Toxicology, 55, 161-171 (Pubitemid 19094987)
44. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release, 113, 189-207 (Pubitemid 43983041)
45. Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci, 96, 2-15 (Pubitemid 46323203)
46. Roche JK, Stone MK, Gross LK, Lindner M, Seaner R, Pincus SH, Obrig TG. (2008). Post-exposure targeting of specific epitopes on ricin toxin abrogates toxin-induced hypoglycemia, hepatic injury, and lethality in a mouse model. Lab Invest, 88, 1178-1191
47. Sandvig K, Torgersen ML, Engedal N, Skotland T, Iversen TG. (2010). Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine. FEBS Lett, 584, 2626-2634
48. Schep LJ, Temple WA, Butt GA, Beasley MD. (2009). Ricin as a weapon of mass terror-separating fact from fiction. Environ Int, 35, 1267-1271
49. Scherphof GL, Kamps JA. (2001). The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog Lipid Res, 40, 149-166 (Pubitemid 32220186)
50. Schümann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, Tiegs G. (2000). Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol, 157, 1671-1683
51. Sha O, Yew DT, Ng TB, Yuan L, Kwong WH. (2010). Different in vitro toxicities of structurally similar type I ribosome-inactivating proteins (RIPs). Toxicol In Vitro, 24, 1176-1182
52. Simmons BM, Stahl PD, Russell JH. (1987). In vivo depletion of mannose receptor bearing cells from rat liver by ricin A chain: effects on clearance of beta-glucuronidase. Biochem Biophys Res Commun, 146, 849-854
53. Skilleter DN, Foxwell BM. (1986). Selective uptake of ricin A-chain by hepatic non-parenchymal cells in vitro. Importance of mannose oligosaccharides in the toxin. FEBS Lett, 196, 344-348 (Pubitemid 16047489)
54. Skilleter DN, Paine AJ, Stirpe F. (1981). A comparison of the accumulation of ricin by hepatic parenchymal and nonparenchymal cells and its inhibition of protein synthesis. Biochim Biophys Acta, 677, 495-500 (Pubitemid 12207077)
55. Stirpe F. (2004). Ribosome-inactivating proteins. Toxicon, 44, 371-383 (Pubitemid 39070639)
56. Stone WL, Smith M. (2004). Therapeutic uses of antioxidant liposomes. Mol Biotechnol, 27, 217-230 (Pubitemid 41490590)
57. Suntres ZE. (2002). Role of antioxidants in paraquat toxicity. Toxicology, 180, 65-77 (Pubitemid 35248093)
58. Suntres ZE, Hepworth SR, Shek PN. (1992). Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity. Biochem Pharmacol, 44, 1811-1818
59. Suntres ZE, Shek PN. (1996). Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock, 6 Suppl 1, S57-S64 (Pubitemid 126727797)
60. Suntres ZE, Shek PN. (1998). Prophylaxis against lipopolysaccharideinduced acute lung injury by alpha-tocopherol liposomes. Crit Care Med, 26, 723-729 (Pubitemid 28201420)
61. Suntres ZE, Shek PN. (2000). Prophylaxis against lipopolysaccharideinduced lung injuries by liposome-entrapped dexamethasone in rats. Biochem Pharmacol, 59, 1155-1161 (Pubitemid 30110509)
62. Suntres ZE, Stone WL, Smith MG. (2005). Ricin-Induced Tissue Toxicity: The Role of Oxidative Stress. J Med CBR Def 3
63. Thorpe PE, Detre SI, Foxwell BM, Brown AN, Skilleter DN, Wilson G, Forrester JA, Stirpe F. (1985). Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur J Biochem, 147, 197-206
64. Traeger T, Mikulcak M, Eipel C, Abshagen K, Diedrich S, Heidecke CD, Maier S, Vollmar B. (2010). Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis. Eur J Gastroenterol Hepatol, 22, 1039-1049
65. Uchida K. (2007). Future of toxicology-lipid peroxidation in the future: from biomarker to etiology. Chem Res Toxicol, 20, 3-5. (Pubitemid 46220148)
66. Wasserman V, Kizelsztein P, Garbuzenko O, Kohen R, Ovadia H, Tabakman R, Barenholz Y. (2007). The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release. Langmuir, 23, 1937-1947 (Pubitemid 46406145)
67. Westwood FR, Jones DV, Aldridge A. (1996). The synovial membrane, liver, and tongue: target organs for a ricin A-chain immunotoxin (ZD0490). Toxicol Pathol, 24, 477-483 (Pubitemid 26274857)
68. Wu J, Liu L, Yen RD, Catana A, Nantz MH, Zern MA. (2004). Liposomemediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice. Hepatology, 40, 195-204 (Pubitemid 38868938)
69. Wu J, Nantz MH, Zern MA. (2002). Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci, 7, d717-d725
70. Zenilman ME, Fiani M, Stahl P, Brunt E, Flye MW. (1988). Use of ricin A-chain to selectively deplete Kupffer cells. J Surg Res, 45, 82-89